Sera Prognostics (SERA) FCF Margin (2020 - 2026)
Sera Prognostics (SERA) posted FCF Margin of 62728.57% for Q1 2026, up 2.75% on a QoQ basis from 64500.0% in Q4 2025, and down 4284436.0% year-over-year from N/an in Q1 2025.
Sera Prognostics (SERA) FCF Margin (2020 - 2026) Analysis & Trends
Sera Prognostics' FCF Margin history runs 7 years deep, the most recent figure standing at 62728.57% for Q1 2026.
- Quarterly FCF Margin fell 4284436.0% year-over-year to 62728.57% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 48377.19% (down 2509024.0% YoY) and the FY2025 annual result came in at 32529.63%, down 1402963.0% from the prior year.
- FCF Margin was 62728.57% for Q1 2026 at Sera Prognostics, up from 64500.0% in the prior quarter.
- Across five years, FCF Margin topped out at 4920.0% in Q1 2023 and bottomed at 64500.0% in Q4 2025.
- A 5-year average of 25142.74% and a median of 22047.28% in 2024 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin jumped 3176652 bps — and 2026, when it tumbled 4284436 bps.
- Sera Prognostics' FCF Margin stood at 11432.31% in 2022, then sank by 45 bps to 16539.02% in 2023, then plunged by 58 bps to 26116.67% in 2024, then slumped by 147 bps to 64500.0% in 2025, then rose by 3 bps to 62728.57% in 2026.
- Business Quant data shows SERA's FCF Margin at 62728.57% in Q1 2026, 64500.0% in Q4 2025, and 41181.25% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sera Prognostics | 109.06 Mn | 109.06 Mn | -28,000.00 | -62,728.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62,728.57% |
| Dec 31, 2025 | -64,500.00% |
| Sep 30, 2025 | -41,181.25% |
| Jun 30, 2025 | -33,847.06% |
| Mar 31, 2025 | -19,884.21% |
| Dec 31, 2024 | -26,116.67% |
| Sep 30, 2024 | -24,210.34% |
| Jun 30, 2024 | -24,729.17% |
| Dec 31, 2023 | -16,539.02% |
| Sep 30, 2023 | -18,142.86% |
| Jun 30, 2023 | -6,500.00% |
| Mar 31, 2023 | -4,920.00% |
| Dec 31, 2022 | -11,432.31% |
| Sep 30, 2022 | -10,516.09% |
| Jun 30, 2022 | -11,867.95% |
| Mar 31, 2022 | -25,168.42% |
| Dec 31, 2021 | -38,080.77% |
| Sep 30, 2021 | -42,282.61% |
| Jun 30, 2021 | -31,615.00% |
| Mar 31, 2021 | -53,776.92% |